Warner Bros. Discovery, Inc.
S1P1 agonist and application thereof
Last updated:
Abstract:
The present invention relates to a class of tricyclic compounds and an application thereof as a sphingosine 1-phosphate type 1 (S1P1) receptor agonist. The invention specifically relates to a compound represented by formula (II), and a tautomer and pharmaceutically acceptable salt of same. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
21 Jul 2017
Issue date:
7 Dec 2021